Painkillers

FDA tempers opioid approval impact

FDA tempers opioid approval impact

By

The Center for Drug Evaluation and Research's director says there is a need for new opioids and cuts off dosing comparisons between extended-release and immediate-release opioids.

Advocates want FDA's Hamburg out

The reason: opioids.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

FDA wants more info on Acura pain drug

FDA wants more info on Acura pain drug

By

FDA feedback will influence a new clinical trial design, but the regulator's recent reaction was a bit of a surprise.

Zohydro to get marketing overhaul

Zohydro to get marketing overhaul

By

The painkiller's marketer will look to partner with another manufacturer to better target primary care physicians, and will also reexamine its sales territories.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.

Purdue pain drug gets priority status

Purdue pain drug gets priority status

By

Purdue Pharma expects the FDA to vote yea or nay on the drug by October.

Zohydro's second act

Zogenix is working on a less easily abused formulation of its controversial prescription painkiller.

CDC: US is biggest Rx opioid market

CDC: US is biggest Rx opioid market

By

The Centers of Disease Control reports that prescribers wrote enough painkiller prescriptions to give one bottle to every adult in the US in 2012.

Study: Opioid deaths outnumber heroin-associated ones

Study: Opioid deaths outnumber heroin-associated ones

By

Researchers at Montreal's McGill University survey the explosion in prescription painkiller use and abuse.

Seniors are major painkiller users

A USA today analysis shows Medicare painkiller prescriptions rose 30% between 2007 and 2012.

Top opioid prescribers not pain specialists

Express Scripts said that family and internal medicine doctors were the top opioid prescribers between 2011 and 2012.

CA counties sue makers of painkillers

Orange and Santa Clara counties are suing painkiller makers like Purdue and Endo, a suit akin to deceptive ad cases launched against the tobacco industry.

FDA standing by its Zohydro approval

FDA standing by its Zohydro approval

By

The regulator defends its approval decision in a web post.

New painkillers stalk Zohydro

New painkillers stalk Zohydro

By

Two drugmakers, Purdue Pharma and Teva, have abuse-deterrent hydrocodone medications either under FDA review or in late-stage testing.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Massachusetts bans Zohydro

The Bay State is saying no to the controversial prescription painkiller.

Senator seeks anti-Zohydro legislation

West Virginia's Joe Manchin has sponsored a bill to push pain medication Zohydro off the FDA's approval list.

Possible Zohydro competitor surfaces

Possible Zohydro competitor surfaces

By

A rival's late-stage trial results suggest the pain med may have a short market life. The key: an FDA division head's documented willingness to overturn the approval should another pain option surface.

Doctors, not friends, source of many opioids

A study says that more opioid abusers get their medications via prescription than they do second-hand.

State database cuts pain overprescribing

New York's health commissioner says its painkiller prescription database has cut painkiller doctor shopping by 75%.

Judge: Teva not liable for Oxycontin patent violation

Purdue Pharma says it will appeal.

CVS joins prescription crackdown

By

The drugstore chain says it has cut off over-prescribers of tightly controlled medications.

J&J painkiller probe expands scrutiny of industry marketing

By

HHS is looking into how J&J marketed opioid painkiller Nucynta, adding to the firm's list of investigations and those of the industry as a whole.

Actavis gets go-ahead to expand generic painkiller portfolio

By

The drug maker can now add five new doses to its generic Opana ER offerings.

FDA move gives Purdue edge in painkiller market

FDA move gives Purdue edge in painkiller market

By

Generic Opana ER got the go-ahead from FDA, exposing the drugmaker to generic competition -- unlike Purdue, whose tamper-proof painkiller won standalone status.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters